←
Mandl Lab75 posts
Mandl Lab avatar

Mandl Lab

@MandlLab

Immune cell dynamics, migration, and diversity in cells & people @mcgillu. Account run by an exceptional team of trainee-clowns 🧑‍🔬🤡, with critical PI input.

◷ Joined June 2022▧ 22 Photos and videos
Mandl Lab avatar
Mandl Lab@MandlLab·4 Dec 2024

Huge congratulations to Dr. Connie Shen @peepingcells on delivering an outstanding thesis defense! Our fourth Mandl PhD will soon be leaving the nest, trading cold Montréal for sunny California! ☀️All the best!

Post attachmentPost attachment
Mandl Lab avatar
Mandl Lab@MandlLab·5 Feb 2024

Interestingly, against a chronic fungal infection 🍄that T cells can't clear, both our model and experiments agreed that this TCR diversity didn't offer any extra protection. So, it seems that these low-binding TCRs are useful for certain chronic battles!

Post attachment
Mandl Lab avatar
Mandl Lab@MandlLab·5 Feb 2024

But does TdT contribute primarily to low-reactivity T cells? We show experimentally that this is indeed the case, with TdT-deficient T cells (🔴) 1) binding viral antigens stronger, on average, and 2) clearing a chronic viral infection slower than TdT-sufficient T cells.

Post attachment
Mandl Lab avatar
Mandl Lab@MandlLab·5 Feb 2024

Our model showed that, unlike with acute infections (🟣) skewing the response toward reactive (but more readily exhausted😪) T cells, chronic infections (🟠) instead lead to a dominance of more “endurant” T cells with weaker antigen binding strengths (ie “looser” handshakes 🤝).

0:10
Mandl Lab avatar
Mandl Lab@MandlLab·5 Feb 2024

We hypothesized that TdT-diversified TCRs had lower antigen binding strengths (pMHC reactivity) on average, and that these T cells would specifically benefit clearance of chronic pathogens- and we started by designing a computational model to test this idea.

Post attachment
Mandl Lab avatar
Mandl Lab@MandlLab·5 Feb 2024

Yes, but… if you take away ~90% of TCR repertoire diversity in mice 🐁 by removing a DNA polymerase called TdT, acute pathogen control is unaffected- so what exactly does this additional diversity by TdT DO? 🧐 This is exactly the question we sought to answer in this work ✨

Mandl Lab avatar
Mandl Lab@MandlLab·5 Feb 2024

T cells are a crucial line of defence 💪for our bodies’ fight against foreign pathogens- and given the enormous variety of bugs 🦠 out there, we need a diverse pool of T cells, each with a unique T cell receptor (TCR), to adequately respond to these challenges… right? 🤔

Mandl Lab avatar
Mandl Lab@MandlLab·5 Feb 2024

Check out our recent publication in collaboration with the Khadra Lab at @mcgillu - where computational modelling 🖥️ and experimental immunology 🔬join forces to study the role of T cell diversity and antigen binding strength on chronic infection clearance! Find out more 👇

>90% of #TCR sequence diversity is generated by TdT-mediated nucleotide addition, but what is the benefit of TdT-altered TCRs? @MandlLab show that low-affinity #Tcells generated by TdT are important for curtailing chronic pathogen replication #PLOSBiology plos.io/3HJKOCl

Post attachment
Meetings d'Immunologie Montréal avatar
⟳ Mandl Lab retweeted
Meetings d'Immunologie Montréal@MIM_immuno·22 Jan 2024

First MIM happy hour of the year is tomorrow! Who else is coming? 😎 Le premier 5 à 7 de l'année de MIM est demain! Qui d'autre prévoit y être? 👀

Bonne année à tous! // Happy New year to all! Reminder! The next MIM happy hour will be from 5 to 7 PM on January 23, 2024 @ Pub l'Île Noire 🍻🍕 Rappel! Le prochain 5 à 7 de MIM sera le 23 janvier 2024 au Pub l'Île Noire   See image for details // voir l'image pour détails

Post attachment
Melichar Lab avatar
⟳ Mandl Lab retweeted
Melichar Lab@MelicharLab·10 Jan 2024

Excited to share a new preprint from our group! Marie-Ève and team demonstrate an unexpected role for NGFR/CD271 in directly suppressing T cell activity! biorxiv.org/content/10.1101/…